Proposed FDA Rule Targets Asbestos in Talc Cosmetic Products

Follow Drugslib on

Medically reviewed by Drugs.com.

By India Edwards HealthDay Reporter

FRIDAY, Dec. 27, 2024 -- The U.S. Food and Drug Administration (FDA) has proposed a new rule to require standardized testing of talc-containing cosmetics for asbestos, a known carcinogen linked to serious illnesses such as lung and ovarian cancers.

According to an FDA report, the proposed rule would mandate that manufacturers test each batch of talc-containing cosmetic products using advanced microscopy techniques, including polarized light and transmission electron microscopy.

Failure to comply with these testing or record-keeping requirements would result in the products being classified as adulterated under the Federal Food, Drug, and Cosmetic Act.

Asbestos contamination in talc-based cosmetics has been a long-standing health concern.

The FDA emphasized there is no safe level of asbestos exposure, and this rule aims to reduce harmful exposure and protect consumers from potential health risks.

The FDA’s announcement comes as Johnson & Johnson faces lawsuits from over 62,000 claimants alleging asbestos in its talc products caused cancer.

The company has denied the allegations, calling its products safe, and is working to resolve claims through a $10 billion settlement in bankruptcy.

The proposed rule is now open for public and industry comments for 90 days before being finalized, according to a news release from CNN.

Sources

  • U.S. Food and Drug Administration (FDA), news release, Dec. 26, 2024
  • CNN

    • Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

    Source: HealthDay

    Posted : 2024-12-28 00:00

    Read more

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    Popular Keywords